Medical/Pharmaceuticals
Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17
* Nuvaxovid™ COVID-19 vaccine is the first protein-based option for adolescents aged 12 through 17 inEurope GAITHERSBURG, Md., July 5, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious inf...
2022-07-05 23:37
5012
NHS Scotland awards national laboratory medicine framework to Citadel Health
EDINBURGH, Scotland, July 5, 2022 /PRNewswire/ -- Scotland is on its way to
becoming home to the UK's largest connected laboratory medicine network,
following the appointment ofCitadel Health
2022-07-05 14:26
2457
Endurance RP Limited (SEHK:0575.HK) Operational Update on the PE Prevention Drug Fortacin™ / Senstend™
Phase 3 Study in China is Estimated to Complete in November 2022 HONG KONG, July 5, 2022 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to provide updates on the PE prevention drug - Fo...
2022-07-05 12:06
4419
Breakthrough radiology AI provider annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances
Seasoned health technology executive Lakshmi Gudapakkam to become CEO and former HCA Healthcare, Inc. executive DrRick Abramson appointed as Chief Medical Officer. New leadership team to drive expansion of world's first comprehensive AI radiology platform globally and entry into the US. CADt F...
2022-07-05 12:00
2974
Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System
* Lunit and FujiFilm Thailand to supply Lunit INSIGHT CXR and Lunit INSIGHT MMG to one of SEA's largest hospital using Microsoft Azure * Aim to detect cancer in early stages and spearhead medical innovation through AI across the SEA region SEOUL, South Korea, July 4, 2022 /PRNewswire/ -- Luni...
2022-07-04 21:00
4745
JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma
SHANGHAI, July 4, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of phase I clinical study of JWATM204 in patients with advanced ...
2022-07-04 19:30
6268
Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders
LACHEN, Switzerland, July 4, 2022 /PRNewswire/ -- * Octapharma to present new clinical and scientific data from across Octapharma's haematology and critical care portfolios during the ISTH 2022 Congress * Data to be presented in 11 poster presentations and during two Supported Symposia * N...
2022-07-04 18:00
4154
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
HANGZHOU and SHAOXING, China, July 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus (HIV) infection, which was initiated by Shangh...
2022-07-04 08:10
3960
Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis
SAN FRANCISCO and SUZHOU, China, July 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and ot...
2022-07-04 08:00
4245
Brii Biosciences Exercises Option for Vir Biotechnology's VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China
Exclusive development and commercialization rights to VIR-3434 in China strengthen Company's leadership and robust clinical pipeline in HBV Key partnership with Vir enables multitude of combination treatment options as part of Company's strategic approach to developing a functional cure for HBV ...
2022-07-04 07:10
4900
GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia
Building public trust and educating on the importance of getting vaccinated KUALA LUMPUR, Malaysia, July 1, 2022 /PRNewswire/ -- GSK is a science-led global healthcare company, delivering vaccines that help protect people at all stages of life. GSK's new purpose is to unite science, technology an...
2022-07-01 09:16
3748
Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS
GOTHENBURG, Sweden, July 1, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) ("Mentice") Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on9th June 2022, now has been completed. The information was submitted for re...
2022-07-01 03:42
3566
Tencent Cloud and Millennium Technology Services Roll Out i-Care to Connect Patients, Families and Caregivers, Delivering Seamless Comfort Care Anytime, Anywhere
The Tencent Cloud-backed solution aims to help improve patients' experience and quality of life SINGAPORE, June 30, 2022 /PRNewswire/ -- Customers' habits and expectations have evolved dramatically over the last few years across various industries including the medical and healthcare field, driv...
2022-06-30 22:00
5894
Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover
HONG KONG, June 30, 2022 /PRNewswire/ -- The Bund Finance Center (BFC) in Shanghai officially resumed dine-in services at restaurants starting from 29 June. At present, Fosun's businesses and shopping centers inShanghai, including the BFC, Yuyuan Tourist Mart, Forte Woli City, and Orstar City Zhe...
2022-06-30 20:43
5033
Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms
- Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire® - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment - 87.8% said they would recommend treatmen...
2022-06-30 19:00
3109
Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK
MELBOURNE, Australia, June 30, 2022 /PRNewswire/ -- UK consumers will again be able to buy VIRALEZE™, an easy-to-use barrier nasal spray, from LloydsPharmacy, following its relaunch online, with instore availability to follow shortly. Extensive antiviral testing undertaken at the globally renowne...
2022-06-30 12:41
2473
DigiconAsia readers honor Asia Pacific's digital innovators
The inaugural DigiconAsia DX Solution Excellence Awards
2022-06-30 12:00
5224
Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan
SHANGHAI, June 30, 2022 /PRNewswire/ -- Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabi...
2022-06-30 08:00
4635
Insurance providers can assess customer health risks in real-time using contactless vital sign monitoring solution from NuraLogix
LAS VEGAS, June 29, 2022 /PRNewswire/ -- Insurance providers are now able to evaluate customer health risks in real-time using a revolutionary contactless wellness and vital sign monitoring solution fromNuraLogix. The application allows insurance providers to quickly perform a customer health ...
2022-06-29 21:05
2971
BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures
NEW YORK, June 29, 2022 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") is pleased to announce that its client,BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has successfully entered into a co-development agreement withGenFleet Therapeutics, Inc., an immuno-oncology focused biopharmaceutical company b...
2022-06-29 20:00
4433
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34
H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
59917
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
55153
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
52974
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
22439
Lorikeet Dreamweaver enables businesses to give every customer an AI account manager
2026-11-04 22:00
17777